bIosimilar of aDalimumab, an European evAluation

Clinical trial NCT05190484 · UNKNOWN

Trial details

NCT number: NCT05190484
Sponsor: Fresenius Kabi
Status: UNKNOWN
Study type: OBSERVATIONAL

Rheumatoid Arthritis Ankylosing Spondylitis Psoriatic Arthritis Crohn Disease Ulcerative Colitis

Start date: 2022-04-30
Primary completion: 2023-04-30
Enrollment: 1050

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.